Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.330
-0.080 (-2.35%)
Sep 18, 2026, 4:00 PM EDT - Market closed

Pyxis Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
27872938047353
Market Cap Growth
102.65%-22.81%16.32%70.77%-86.78%-
Enterprise Value
26314-32-32-136414
Last Close Price
3.331.151.561.801.3410.97

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
25.165.175.75---
PB Ratio
18.461.340.770.630.291.35
P/TBV Ratio
24.281.340.790.790.291.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
23.791.04----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.560.350.170.170.120.00
Net Debt / Equity Ratio
-1.33-0.90-0.88-0.78-1.00-1.05
Net Debt / EBITDA Ratio
0.180.621.711.251.313.98
Net Debt / FCF Ratio
0.220.761.841.261.687.66
Asset Turnover
0.120.110.10---
Quick Ratio
1.203.207.184.635.6914.69
Current Ratio
1.343.417.494.845.9014.90
Return on Equity (ROE)
-179.10%-91.44%-62.76%-51.51%-57.19%-56.78%
Return on Assets (ROA)
-62.95%-41.14%-24.77%-26.10%-31.41%-30.03%
Return on Capital Employed (ROCE)
-326.80%-116.30%-47.00%-54.30%-68.70%-26.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-31.95%-111.20%-83.36%-92.53%-258.50%-21.50%
FCF Yield
-24.45%-88.70%-62.42%-97.10%-205.00%-10.15%
Buyback Yield / Dilution
-3.27%-6.33%-46.46%-20.80%-288.93%-724.14%
SEC Filings: 10-K · 10-Q